AF | atrial fibrillation |
DOAC | direct oral anticoagulant |
HF | heart failure |
LVEF | left ventricular ejection fraction |
PAD | peripheral artery disease |
VKA | vitamin K antagonist |
AF | atrial fibrillation |
DOAC | direct oral anticoagulant |
HF | heart failure |
LVEF | left ventricular ejection fraction |
PAD | peripheral artery disease |
VKA | vitamin K antagonist |